Latest filing published 15 Dec 2023 for China Regenerative Medicine International Ltd., €1.9M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 14 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -28.0%Entry HK$0.59 · Close at T+365 HK$0.43
- -48.8%Entry HK$1.66 · Close at T+365 HK$0.85
- -47.7%Entry HK$1.72 · Close at T+365 HK$0.90
- -40.8%Entry HK$1.52 · Close at T+365 HK$0.90
- -49.4%Entry HK$1.70 · Close at T+365 HK$0.86
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Wang Chuang: trading record in brief
Wang Chuang discloses dealings in China Regenerative Medicine International Ltd. to HKEX. The record holds 14 filings, for trades running from 29 November 2019 to 13 December 2023.
The open-market record is one-sided, with 14 purchases worth €28.6M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2023: 1 purchase and no sales on the market.
The median purchase comes to €67k. On 7 out of 14 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. Looking at 14 purchases old enough to measure, the stock rose over the following 90 days in 21% of cases; the median change was -6.1%. This is a record of the past, not a forecast.
On 15 December 2023 came the latest disclosure, an open-market purchase for €1.9M in China Regenerative Medicine International Ltd. Between a trade and the moment it shows up on HKEX, the median delay is 1 day. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Companies and markets linked to Wang Chuang
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 18,823,530 shares@ HK$0.856.6% of flowShareXHKGHKEX:DA20231215E00140Canonical exit: 12 Mar 2024 (T+90)
- 2,695,000 shares@ HK$0.170.2% of flowShareXHKGHKEX:DA20220916E00228Canonical exit: 14 Dec 2022 (T+90)
- 3,080,000 shares@ HK$0.16590.2% of flowShareXHKGHKEX:DA20220908E00132Canonical exit: 6 Dec 2022 (T+90)
- 3,100,000 shares@ HK$0.1650.2% of flowShareXHKGHKEX:DA20220906E00252Canonical exit: 4 Dec 2022 (T+90)
- 2,975,000 shares@ HK$0.1660.2% of flowShareXHKGHKEX:DA20220829E00222Canonical exit: 24 Nov 2022 (T+90)
- 265,290,000 shares@ HK$0.42541.5% of flowShareXHKGHKEX:DA20210111E00403Canonical exit: 8 Apr 2021 (T+90)
- 740,000 shares@ HK$0.40960.1% of flowShareXHKGHKEX:DA20210108E00053Canonical exit: 7 Apr 2021 (T+90)
- 140,000,000 shares@ HK$0.5428.1% of flowShareXHKGHKEX:DA20201214E00330Canonical exit: 14 Mar 2021 (T+90)
- 107,500,000 shares@ HK$0.5120.5% of flowShareXHKGHKEX:DA20201211E00380Canonical exit: 10 Mar 2021 (T+90)
- 2,455,000 shares@ HK$0.23930.2% of flowShareXHKGHKEX:DA20191209E00129Canonical exit: 4 Mar 2020 (T+90)
- 1,135,000 shares@ HK$0.23890.1% of flowShareXHKGHKEX:DA20191209E00128Canonical exit: 3 Mar 2020 (T+90)
- 1,740,000 shares@ HK$0.23840.2% of flowShareXHKGHKEX:DA20191204E00308Canonical exit: 2 Mar 2020 (T+90)
- 4,560,000 shares@ HK$0.22210.4% of flowShareXHKGHKEX:DA20191203E00070Canonical exit: 1 Mar 2020 (T+90)
- 15,250,000 shares@ HK$0.22091.4% of flowShareXHKGHKEX:DA20191129E00307Canonical exit: 27 Feb 2020 (T+90)
14 of 14 declarations